(Q58826845)
Statements
Possible improved survival of patients with stage IV AJCC melanoma receiving SRL 172 immunotherapy: correlation with induction of increased levels of intracellular interleukin-2 in peripheral blood lymphocytes (English)
A Maraveyas
B Baban
D Kennard
M Westby
J M Grange
P Lydyard
J L Stanford
M Jones
P Selby